JACOBS LEVY EQUITY MANAGEMENT, INC Enanta Pharmaceuticals, Inc. Transaction History

JACOBS LEVY EQUITY MANAGEMENT, INC portfolio value:

$18.27M
portfolio value

JACOBS LEVY EQUITY MANAGEMENT, INC quarter portfolio value change:

+9.73%
quarter

Enanta Pharmaceuticals, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +18.41% 54.77K shares 4.21M $51.87 352.30K
Q2 2022 share Increase +6.86% 19.10K shares -5.75M $47.27 297.53K
Q1 2022 share Increase +3.07% 8.29K shares -382K $71.18 278.42K
Q4 2021 share Increase +6.43% 16.31K shares 5.78M $74.57 270.13K
Q3 2021 share Decrease -2.21% -5.73K shares 2.99M $56.81 253.81K
Q2 2021 share Increase +7.14% 17.29K shares -525K $44.01 259.55K
Q1 2021 share Decrease -2.44% -6.06K shares 1.49M $49.32 242.25K
Q4 2020 share Decrease -3.02% -7.74K shares -1.26M $42.1 248.32K
Q3 2020 share Decrease -3.10% -8.19K shares -1.54M $45.78 256.06K
Q2 2020 share Increase +54.73% 93.47K shares 4.48M $50.21 264.26K
Q1 2020 share Increase +99.08% 84.99K shares 3.48M $51.43 170.78K
Q4 2019 share Increase +20.19% 14.41K shares 1.01M $61.78 85.78K
Q3 2019 share Increase +23.05% 13.37K shares -606K $60.08 71.37K
Q2 2019 share Increase 0.00% 58.00K shares 4.89M $84.38 58.00K
Q4 2018 share Decrease -100.00% -26.82K shares -2.29M $70.83 0
Q3 2018 share Increase +111.58% 14.14K shares 823K $85.46 26.82K
Q2 2018 share Decrease -55.86% -16.04K shares -855K $115.9 12.67K
Q1 2018 share Decrease -2.31% -680 shares 599K $80.91 28.72K
Q4 2017 share Increase 0.00% 29.4K shares 1.72M $58.68 29.4K
Q2 2016 share Decrease -100.00% -13.99K shares -411K $22.05 0
Q1 2016 share Increase 0.00% 13.99K shares 411K $29.37 13.99K